We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Synthetic Ribozyme Generates Novel Proteins

By Biotechdaily staff writers
Posted on 12 Jul 2002
An automated method has been developed for generating aminoacyl tRNAs that are charged with non-natural amino acids that can be incorporated into proteins through cell-free translation. More...
The new technology has been described in two articles. The first, in the July 2002 issue of Nature Biotechnology, showed how an artificial ribozyme could build proteins from tRNAs using amino acids not normally used to build proteins. The second article, in the June 19, 2002, issue of the Journal of the American Chemical Society, described an automated method employing immobilized synthetic ribozymes.

In this procedure, the scientists immobilized the ribozymes on an inexpensive gel, packed the resin into a column, added the amino acid and tRNA, and shook the mixture for about half an hour. "When the resin is washed off, what is left is the aminoacyl-tRNA with the immobilized ribozyme,” explained Dr. Hiroaki Suga, professor of chemistry at Buffalo University (NY, USA). "The desired aminoacyl-tRNA can then be isolated. It is a very durable and convenient system.” The system is economical and may be reused numerous times, said the scientists.

The advantage of using so-called unnatural or non-natural amino acids designed in the lab is that they can be tailored with special functions that are not available in natural amino acids and that will aid researchers working in proteomics. "Our system has the potential to provide a simple method for the preparation of such aminoacyl-tRNAs for researchers who want to expand the amino-acid repertoire for protein synthesis,” said Dr. Suga.



Related Links:
Univ. of Buffalo

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Pipette Calibration System
Artel PCS®
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.